Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects.

ABSTRACT:

Objective

To evaluate long-term efficacy and safety of bimatoprost for treatment of chemotherapy-induced eyelash hypotrichosis.

Design

One-year, multicenter, double-masked, parallel-group study.

Setting

Twenty-one centers in the United States and one center in the United Kingdom.

Participants

This study randomized (3:1) 130 subjects to bimatoprost 0.03% or vehicle applied topically to upper eyelid margins for six months. All subjects used bimatoprost for a second six months.

Measurements

Responders for the primary composite end point achieved ≥1-grade improvement in Global Eyelash Assessment score and ≥3-point improvement in Confidence, Attractiveness, and Professionalism domain score of the Eyelash Satisfaction Questionnaire at Month 4. Secondary assess

SUBMITTER: Wirta D 

PROVIDER: S-EPMC4456802 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature